The urokinase-type plasminogen activator receptor (uPAR) 1 is a multifunctional membrane glycoprotein primarily involved in the regulation of pericellular proteolysis due to its high affinity interaction with the growth factor-like module of urokinase-type plasminogen activator (uPA) (1), but which has also been implicated in the promotion of cell adhesion due to its vitronectin and integrin binding properties (2), in signal transduction (3) and chemotaxis (4, 5). However, the uPA-uPAR interaction per se is intimately coupled to the latter "nonproteolytic" functions of uPAR, since this interaction either elicits or modulates these events. Cell surfaces expressing uPAR constitutes favored microenvironments for uPA-mediated plasminogen activation (6). Consequently, the uPA-uPAR interaction represents an attractive molecular target for the development of small receptor binding antagonists that may prove useful during treatment of certain diseases in which uPAR has been implicated, i.e. cancer invasion and metastasis (7-13).uPAR is a glycosylphosphatidylinositol-anchored plasma membrane protein (14) having an extracellular part composed of three homologous domains belonging to the Ly-6/uPAR protein domain family, 2 as reviewed (15). This family is dominated by single domain proteins among which the glycolipid-anchored members are found primarily in mammalians (i.e. CD59, Ly-6, E48, and ThB) whereas the secreted members belong to either reptiles or amphibians (i.e. ␣-neurotoxins, fasiculins, cardiotoxins, and xenoxins). Intriguingly, a similar phylogenetic relationship exists for the few family members identified so far containing two Ly-6/uPAR domains, i.e. the glycolipid anchored RoBo-1 (16) and metastasis-associated C4.4 (17) isolated from rat versus the secreted phospholipase A2 inhibitor isolated from cobra blood (18). Comparison of the three-dimensional protein structures available for several single domain members of this protein family reveals a "three finger" consensus structure consisting of 3 loops, a central 3-stranded -sheet, and a globular, disulfide-rich core (19 -21). The individual domains of uPAR (numbered I, II and III) are thought to adopt a similar "three finger fold" (15).The involvement of uPAR domain I (residues 1-87) 3 in uPA binding is demonstrated by several lines of evidence. First, uPAR domain I can be specifically cross-linked to a receptor binding derivative of uPA using two different chemical crosslinking reagents (23,24). Second, the uPA-uPAR interaction can be inhibited competitively by monoclonal antibodies recognizing epitopes on uPAR domain I (25-27). Third, uPAR domain I is also a target for the specific photoinsertion from a small peptide antagonist of uPA binding (28). Specific proteolytic cleavage after Tyr 87 , situated in the linker region between domains I and II, is, however, also accompanied by a Ͼ1,500-fold reduction in the affinity for uPA (⌬⌬G Ͼ 4 kcal/mol), which clearly emphasizes the necessity of the multidomain structure of uPAR for high affinity ligand binding (2...